Thiobutabarbital
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
Synonyms | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
CAS Number | 2095-57-0 N |
PubChem (CID) | 3032373 |
ChemSpider | 2297366 Y |
UNII | 2N0251U7JH Y |
ECHA InfoCard | 100.016.600 |
Chemical and physical data | |
Formula | C10H16N2O2S |
Molar mass | 228.312 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
NY (what is this?) (verify) |
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [1]
References
- ↑ Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.